(Q66925205)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:478651%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

title

The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:478651%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1 reference

M. Stephens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A478651

3 June 2023

M. Potten

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A478651

3 June 2023

A. J. Bint

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A478651

3 June 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=478651

3 June 2023

publication date

1 January 1979

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:478651%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

31 August 2019

http://link.springer.com/content/pdf/10.1007/BF01641308.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/BF01641308

http://link.springer.com/article/10.1007/BF01641308/fulltext.html

3 June 2023

1 reference

https://api.crossref.org/works/10.1007/BF01641308

http://link.springer.com/content/pdf/10.1007/BF01641308

3 June 2023

1 reference

https://api.crossref.org/works/10.1007/BF01641308

3 June 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:478651%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:478651%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:478651%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

page(s)

109-112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:478651%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01641308

31 August 2019

exact match

0 references

cites work

Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.

1 reference

12 December 2020

Experimental evaluation of HR 756, a new cephalosporin derivative: Pre-clinical study

1 reference

12 December 2020

Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms.

1 reference

12 December 2020

Ototoxicity of amikacin

1 reference

12 December 2020

Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli

1 reference

12 December 2020

Experience with amikacin and colistin in an outbreak of infection by resistant Klebsiella aerogenes

1 reference

12 December 2020

Nosocomial Infection Caused by Gentamicin-Resistant, Streptomycin-Sensitive Klebsiella

1 reference

12 December 2020

In Vitro Study of Netilmicin Compared with Other Aminoglycosides

1 reference

12 December 2020

Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods

1 reference

12 December 2020

Controlled Comparison of Amikacin and Gentamicin

1 reference

12 December 2020

Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.

1 reference

12 December 2020

Patterns and Mechanisms of Emergence of Resistance to Amikacin

1 reference

12 December 2020

This is medical progress? Trends and consequences of antibiotic use in the United States.

1 reference

12 December 2020

Cefotaxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro

1 reference

12 December 2020